Diagnostics and research stocks with the lowest price to sales ratio

Ranked

61

of 74 diagnostics and research stocks we cover

Median

4.2×

Lowest

0.3×

BIAF

Range

0.3× to 66.4×

#	Company	P/S	Net margin	Revenue growth (TTM)	Market cap
1	BIAFbioAffinity Technologies	0.3×	n/m	−23.2%	$1.5M
2	AMSAmerican Shared Hospital Services	0.3×	−5.8%	+4.0%	$8.4M
3	QDELQuidelOrtho	0.4×	−39.2%	−2.5%	$941.5M
4	HBIOHarvard Bioscience	0.4×	−11.9%	−1.1%	$37.5M
5	BNGOBionano Genomics	0.4×	n/m	+10.0%	$13.3M
6	MYGNMyriad Genetics	0.7×	−14.0%	−3.2%	$556.7M
7	FTREFortrea	0.8×	−3.2%	−2.1%	$2.2B
8	QTRXQuanterix	0.9×	−80.2%	+22.0%	$135.3M
9	VNRXVolitionrx	1.0×	n/m	+86.3%	$2.4M
10	RPIDRapid Micro Biosystems	1.1×	n/m	+16.1%	$39.1M
11	BGLCBioNexus Gene Lab	1.1×	−82.4%	−67.3%	$3.5M
12	PRPOPrecipio	1.3×	−4.5%	+28.0%	$35.8M
13	FLGTFulgent Genetics	1.7×	−26.0%	+6.8%	$553.1M
14	BMRABiomerica	1.8×	n/m	−11.2%	$7.7M
15	AVTRAvantor	1.8×	−8.8%	−1.6%	$11.7B
16	LHLabcorp	1.9×	7.0%	+6.4%	$26.7B
17	BDSXBiodesix	2.2×	−27.0%	+34.5%	$223.5M
18	DGXQuest Diagnostics	2.3×	9.2%	+9.1%	$26.7B
19	RDNTRadNet	2.4×	−0.9%	+18.9%	$5.5B
20	XGNExagen	2.5×	−26.6%	+20.8%	$176.1M
21	BRKRBruker	2.5×	−2.0%	+1.6%	$8.8B
22	IQVIQVIA	2.7×	8.1%	+8.2%	$46B
23	CSTLCastle Biosciences	2.8×	−5.4%	+3.2%	$1B
24	NEOGNeogen	3.0×	−6.3%	−0.3%	$2.7B
25	ICCCImmucell	3.0×	2.6%	+8.5%	$93.1M
26	NRCNRC Health	3.5×	4.2%	−0.2%	$485.1M
27	CTKBCytek Biosciences	3.5×	−39.0%	+5.4%	$726.6M
28	BIOBio-Rad Laboratories	3.8×	8.6%	+1.4%	$9.9B
29	PACBPacific Biosciences of California	4.1×	−82.5%	+2.0%	$655.9M
30	CRLCharles River Laboratories International	4.1×	−6.0%	−0.7%	$16.5B
31	LNTHLantheus	4.2×	17.7%	+2.3%	$6.5B
32	ISPCiSpecimen	4.4×	n/m	−92.1%	$2.1M
33	MXCTMaxcyte	4.7×	n/m	−13.2%	$144.5M
34	TMOThermo Fisher Scientific	5.3×	14.9%	+8.3%	$249.1B
35	RVTYRevvity	6.1×	8.2%	+4.1%	$17.7B
36	DHRDanaher	6.5×	15.9%	+4.6%	$162B
37	AAgilent Technologies	6.6×	19.5%	+8.6%	$48.8B
38	MEDPMedpace	6.7×	17.7%	+24.7%	$18.7B
39	VCYTVeracyte	6.9×	20.4%	+17.3%	$3.9B
40	SEERSeer	7.7×	n/m	−12.7%	$109.1M
41	MASS908 Devices	7.8×	−57.0%	+13.4%	$474.9M
42	CDNACareDx	7.8×	24.2%	+34.4%	$3.6B
43	TKNOAlpha Teknova	7.9×	−38.4%	+12.3%	$344.7M
44	MTDMettler-Toledo International	8.1×	21.9%	+6.9%	$33.5B
45	ILMNIllumina	9.1×	18.4%	+4.9%	$40.7B
46	CAICaris Life Sciences	9.1×	10.6%	+85.4%	$9B
47	WATWaters	9.6×	3.6%	+52.5%	$44.6B
48	IDXXIDEXX Laboratories	9.7×	25.0%	+12.8%	$44.1B
49	ASTCASTROTECH	11.1×	n/m	−12.9%	$10.1M
50	EYPTEyePoint	12.5×	n/m	−94.6%	$34.9M
51	BLLNBillionToOne	12.8×	9.5%	+90.1%	$5.1B
52	TXG10x Genomics	15.1×	−12.2%	−4.3%	$9.3B
53	OABIOmniAb	17.6×	n/m	+67.0%	$677.5M
54	GHGuardant Health	19.2×	−38.3%	+42.7%	$22.7B
55	ONMDOneMedNet	19.2×	n/m	+216.5%	$27.9M
56	NTRANatera	21.5×	−7.1%	+37.8%	$58.2B
57	PSNLPersonalis	24.3×	n/m	−13.3%	$1.7B
58	NTLAIntellia Therapeutics	26.4×	n/m	+12.6%	$1.6B
59	GRALGRAIL	35.8×	n/m	+23.1%	$5.9B
60	IMDXInsight Molecular Diagnostics	55.5×	n/m	−60.8%	$92.6M
61	ACONAclarion	66.4×	n/m	+33.1%	$5.6M

Not ranked: 4 with a value too high to mean anything, 4 with not a meaningful number, 2 with a quarter missing. 3 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.